about
Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the DrawbacksCaffeine: cognitive and physical performance enhancer or psychoactive drug?The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performanceCaffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediatorsAdenosine and protection from acute kidney injury.Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysisCaffeine intake antagonizes salt sensitive hypertension through improvement of renal sodium handling.The interplay between drugs and the kidney in premature neonates.Population Pharmacokinetic Characteristics of Amikacin in Suspected Cases of Neonatal Sepsis in a Low-Resource African Setting: A Prospective Nonrandomized Single-Site Study.No evidence of dehydration with moderate daily coffee intake: a counterbalanced cross-over study in a free-living population.Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy.Maternal caffeine administration leads to adverse effects on adult mice offspring.Vigilance and wake EEG architecture in simulated hyperammonaemia: a pilot study on the effects of L-Ornithine-L-Aspartate (LOLA) and caffeine.Biochemical and Pharmacological Role of A1 Adenosine Receptors and Their Modulation as Novel Therapeutic Strategy.Purified Dry Paullinia cupana (PC-18) Extract for Chemotherapy-Induced Fatigue: Results of Two Double-Blind Randomized Clinical Trials.[Mechanisms of caffeine-induced diuresis].Xanthine scaffold: scope and potential in drug development
P2860
Q26740559-9A74C4EE-4CB5-4DC1-A977-BDF2229A0FF0Q28080581-DFA2B819-9C82-4D5F-B3D1-B3BB57C004B1Q28303831-C026BB23-241D-48E6-8706-B5C217A65BADQ34279284-1C503C33-E9DB-47B5-B72C-7DF09A9DF02EQ35755490-2C0FB31A-161D-44B3-B696-CE299F4C3321Q36267436-C42B9F8A-DCAE-4A96-8CE7-2AAA9085AA6EQ36898586-A9F4CE15-4818-4991-AD1D-F91BB2453D81Q38161817-2CF7BE62-A4D6-4F24-9AB4-298CDEF2D613Q38873556-87BBAF44-BDBE-4408-8F4A-B904DD868D79Q41862954-AF603F1E-1B32-4C70-9025-58B1641C9679Q42567312-BF0E13BC-B849-44C5-814F-10B5D24E9E43Q45751820-FFDD5D58-B694-401B-B90D-A36722A90AB2Q47856026-B2E29A9F-4F74-40E0-80A5-E12FFAAA27C1Q48732639-71F65316-C56C-44F1-97C5-16A292DA03B5Q49489332-00497027-8FC6-40AB-A3E2-5AF93A3BD671Q53080189-BD63E53B-C015-44A6-B6A3-49D1C9FAD23DQ57298107-88839C5C-55E6-4BD5-BFB0-24ED8D77730D
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Methylxanthines and the kidney.
@ast
Methylxanthines and the kidney.
@en
type
label
Methylxanthines and the kidney.
@ast
Methylxanthines and the kidney.
@en
prefLabel
Methylxanthines and the kidney.
@ast
Methylxanthines and the kidney.
@en
P2860
P1476
Methylxanthines and the kidney.
@en
P2093
Jürgen Schnermann
P2860
P304
P356
10.1007/978-3-642-13443-2_15
P577
2011-01-01T00:00:00Z